Aster DM Healthcare stock declines 4% on December quarter earnings

The firm's revenue jumped 11 percent in the December quarter to Rs 1,050 crore over Rs 954.67 crore in the year-ago period

Shares of Aster DM Healthcare Ltd declined 4 percent on February 1 in early trading after the company posted a marginal decline in net profit in the December quarter.

The stock was quoting Rs 471.9, down 4 percent on NSE at 10:50 am.

The company has also declared an interim dividend of Rs 4 per equity share.

The healthcare firm on January 31 had reported a consolidated net profit of Rs 56.79 crore in the quarter ended December 31 of the current financial year, compared to Rs 179.21 crore  in the same period of the previous financial year.

However, the firm clarified that Rs 116.2 crore out of the Rs 179.2 crore net profit was from the GCC operations, which is now a segregated entity.

Therefore, the correct comparison is based on the adjusted net profit (post non-controlling interests) for its India business, which saw a growth of 30 percent to Rs 81 crore in Q3FY25, from Rs 62 crore in Q3FY24.

The firm's revenue jumped 11 percent in the December quarter to Rs 1,050 crore over Rs 954.67 crore in the year-ago period. Operating EBITDA rose 20 percent on-year to Rs 202 crore, with margins growing to 19.3 percent from 17.7 percent.

In the April to December period, the company registered a growth of 65 percent in adjusted net profit (post NCI) at Rs 251 crore.

Azad Moopen, founder and chairman, Aster DM Healthcare, said: “As we expand, with plans to surpass ~6,800 beds by FY27, Aster DM Healthcare is well-positioned to meet the increasing demand for advanced healthcare in India.”